Categorisation of breast tumours into sub‐types based on ER, PGR, HER2 expression patterns revealed no statistically significant differences in the overall telomere length distributions or the proportions of tumours with telomere lengths within the length range that provides prognostic significance (Figure 3F). The gene discussed is ERBB2; the disease is breast neoplasm.